This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vaccarino, V. Articles by Krumholz, H. M. Search for Related Content PubMed PubMed Citation Articles by Vaccarino, V. Articles by Krumholz, H. M.

Pulse pressure and risk for myocardial infarction and heart failure in the elderly

Viola Vaccarino, MD, PhD^*, Theodore R. Holford, PhD^* and Harlan M. Krumholz, MD, FACC^*

^* Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut; USA
Department of Medicine (Cardiology), Yale University School of Medicine and Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, Connecticut, USA

View larger version (17K): [in a new window]   Figure 1 Relationship between pulse pressure measured at baseline and incidence of coronary heart disease (CHD), incidence of congestive heart failure (CHF) and total mortality.

View larger version (15K): [in a new window]   Figure 2 Age- and sex-adjusted relative risks (RR) and 95% confidence intervals for the association between pulse pressure (PP) and incidence of coronary heart disease (CHD), after stratification according to hypertension classification. DBP = diastolic blood pressure; DH = diastolic hypertension; ISH = isolated systolic hypertension; SBP = systolic blood pressure.

View larger version (13K): [in a new window]   Figure 3 Age- and sex-adjusted relative risks (RR) and 95% confidence intervals for the association between pulse pressure (PP) and incidence of coronary heart disease (CHD), after stratification according to presence of hypertension (systolic blood pressure 140 or diastolic blood pressure 90 mm Hg) and current use of antihypertensive medications (self-report use or current use of diuretics, beta-blockers, nitrates or nifedipine by direct inspection of medications).